Advertisement
Advertisement

XBIT

XBIT logo

XBiotech Inc

2.34
USD
Sponsored
+0.01
+0.43%
Jun 24, 15:49 UTC -4
Closed
exchange

After-Market

2.35

+0.01
+0.21%

XBiotech Inc Profile

About

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

Info & Links

CEO

Sushma Shivaswamy

Headquarters

5217 WINNEBAGO LANE
AUSTIN, TX 78744, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.xbiotech.com

Auditor

Whitley Penn LLP

Share holders

8

Employees

85

XBiotech Inc Statistics

Valuation Measures

Market Capitalization2

71.49M

Enterprise Value

-43.97M

Enterprise Value/EBITDA(ttm)

0.94

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.51

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-27.80%

Return on Invested Capital(ttm)

-30.00%

Return on Assets(ttm)

-26.67%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-46.83M

Net Income Available to Common(ttm)

-40.16M

Diluted EPS(ttm)

-1.50

Share Statistics

Beta (5Y Monthly)

0.84

52-Week Change

-9.65%

S&P 500 52-Week Change

20.78%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

30.49M

Dividend Yield

0.00%

Float4

21.10M

% Held by Insiders

30.80%

% Held by Institutions

55.70%

Balance Sheet

Total Cash(mrq)

115.46M

Total Cash Per Share(mrq)

3.79

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

16.01%

Quick Ratio(mrq)

16.01%

Book Value Per Share(mrq)

4.60

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.31

Free Cash Flow(ytd)

-40.21M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement